C07H 17/00
Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
C07H17/00 (Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals) appears on 2,072 US grants and 1,647 published applications in this corpus.
Search patents in C07H- Granted patents
- 2,072
- Published applications
- 1,647
- Assignees
- 997
- Inventors
- 5,330
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 23 | 0 |
| 1977 | 25 | 0 |
| 1978 | 18 | 0 |
| 1979 | 34 | 0 |
| 1980 | 34 | 0 |
| 1981 | 21 | 0 |
| 1982 | 30 | 0 |
| 1983 | 27 | 0 |
| 1984 | 33 | 0 |
| 1985 | 26 | 0 |
| 1986 | 29 | 0 |
| 1987 | 23 | 0 |
| 1988 | 18 | 0 |
| 1989 | 32 | 0 |
| 1990 | 40 | 0 |
| 1991 | 47 | 0 |
| 1992 | 40 | 0 |
| 1993 | 34 | 0 |
| 1994 | 31 | 0 |
| 1995 | 41 | 0 |
| 1996 | 41 | 0 |
| 1997 | 58 | 0 |
| 1998 | 57 | 0 |
| 1999 | 47 | 0 |
| 2000 | 60 | 0 |
| 2001 | 42 | 16 |
| 2002 | 68 | 68 |
| 2003 | 78 | 99 |
| 2004 | 67 | 121 |
| 2005 | 51 | 95 |
| 2006 | 55 | 100 |
| 2007 | 48 | 66 |
| 2008 | 43 | 82 |
| 2009 | 42 | 69 |
| 2010 | 42 | 68 |
| 2011 | 49 | 54 |
| 2012 | 42 | 50 |
| 2013 | 61 | 72 |
| 2014 | 67 | 105 |
| 2015 | 57 | 56 |
| 2016 | 51 | 58 |
| 2017 | 45 | 48 |
| 2018 | 37 | 53 |
| 2019 | 42 | 45 |
| 2020 | 42 | 48 |
| 2021 | 35 | 47 |
| 2022 | 34 | 56 |
| 2023 | 34 | 54 |
| 2024 | 23 | 52 |
| 2025 | 33 | 38 |
| 2026 | 15 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Photoisomerized compositions of anthocyanins and methods of making and use thereof14 Jul 2026US 12,679,861 B2Ohio State Innovation Foundation
- ASGPR-binding compounds for the degradation of extracellular proteins30 Jun 2026US 12,667,620 B2Avilar Therapeutics, Inc.
- 7- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)23 Jun 2026US 12,662,471 B2Vertex Pharmaceuticals Incorporated
- Synthesis method for selamectin23 Jun 2026US 12,662,506 B2Zhejiang Rongyao Biotech Co., Ltd.
- Chromogenic and fluorogenic compounds and their use for biological detection23 Jun 2026US 12,663,415 B2AAT Bioquest, Inc.
- Helicase inhibitors8 Oct 2026US 2026/0308196 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Hybrid amide derivatives of amphotericin b17 Sep 2026US 2026/0274882 A1The Board of Trustees of the University of Illinois
- Novel linker compound and ligand-drug conjugate therefor27 Aug 2026US 2026/0248936 A1Trioar, Inc.
- Degrader compounds of qsox1 mrna27 Aug 2026US 2026/0250738 A9University of Florida Research Foundation, Inc.
- N-derivatized sialic acids and related sialosides20 Aug 2026US 2026/0242405 A1The Regents of the University of California
Most cited
By later US patents
- Bis-modified bicyclic nucleic acid analogs253US 7,666,854 B2Isis Pharmaceuticals, Inc. · 2010
- Nucleoside phosphoramidate prodrugs165US 7,964,580 B2Pharmasset, Inc. · 2011
- Selective hydrogenation products of C-076 compounds and derivatives thereof157US 4,199,569 AMerck & Co., Inc. · 1980
- Process for preparing 6-o-substituted erythromycin derivatives150US 6,437,106 B1Abbott Laboratories · 2002
- Chromogenic acridinone enzyme substrates137US 4,810,636 AMiles Inc. · 1989